AstraZeneca's products run the gamut from A (blood pressure drug Atacand) to Z (prostate and breast cancer drug Zoladex). One of the world's major pharmaceutical firms, AstraZeneca specializes in drugs for cardiovascular, metabolic, neurological, gastrointestinal, respiratory, oncology, and infection therapy areas. The firm's biggest sellers include cholesterol reducer Crestor, cardiovascular drug Brilinta, acid reflux remedy Nexium, and Symbicort for asthma. AstraZeneca also markets drugs that aim to treat high cholesterol, diabetes, pain, viral diseases, and various cancers. The company has around 30 factories globally and R&D centers in the UK, US, Sweden, and China, and its products are sold in more than 100 countries.
See detailed business credit reports on other businesses or your own.
See detailed profiles for insights and prospects on this company's top competitors.
Essential information for a successful call
EMPLOYEES (This Site)
- ASSETS (MIL USD) 61,377
REVENUE (MIL USD)
- TICKER SYMBOL AZN
- Incorporated 1993
- FISCAL YEAR END DEC
- SALES GROWTH % 10.38%
Get in Touch with 191 Contacts and 13 Principals*
Marcus WallenbergDirector and Non-Executive Director
Deborah Disanzo EldracherDirector
Sherilyn Dawn MccoyDirector
Sabera Nazneen RahmanDirector